Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study-Reference-Cited by-同舟云学术

Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study

Published:2023-08-17 Issue:4 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Li Rong¹,Ma Jin-Bao¹,Yang Hong¹,Yang Han²,Yang Xin-Jun¹,Wu Yan-Qin¹,Ren Fei¹^ORCID

Affiliation:

1. Department of Drug-resistance tuberculosis, Xi’an Chest Hospital, Xi’an, China

2. Medical Transformation Center of Xi’an Chest Hospital, Xi’an, China

Abstract

Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis . The emergence of MDR-TB is caused by an organism that is resistant to at least isoniazid and rifampin and is currently considered the major challenge for the global control of TB.

Funder

medical research project of science and techology in Xi’an

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.01048-23

Reference25 articles.

1. World Health Organization. 2020. Global tuberculosis report 2020. https://www.who.int/publications/i/item/9789240013131. Retrieved 15 October 2020.

2. Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis

3. Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

4. World Health Organization. 2021. Global tuberculosis report 2021. https://www.who.int/publications/i/item/9789240037021. Retrieved 14 October 2021.

5. Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis